Drug profile · INN
casimersen
AMONDYS 45
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
casimersen (AMONDYS 45) is an FDA-listed pharmaceutical active ingredient. Associated with Sarepta Therapeutics. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN casimersen
Brand AMONDYS 45
Route INTRAVENOUS
Formulation SOLUTION
Originator Sarepta Therapeutics
Frequently asked questions
What is casimersen?
casimersen (AMONDYS 45) is an FDA-listed pharmaceutical active ingredient. Associated with Sarepta Therapeutics. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for casimersen?
AMONDYS 45 is a marketed brand name for casimersen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of casimersen?
casimersen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.